{"nctId":"NCT04615624","briefTitle":"Furosemide vs. Placebo for Severe Antepartum Hypertension","startDateStruct":{"date":"2021-01-04","type":"ACTUAL"},"conditions":["Pre-Eclampsia","Hypertension in Pregnancy","Pregnancy Complications","Hypertension, Pregnancy-Induced"],"count":65,"armGroups":[{"label":"Furosemide","type":"EXPERIMENTAL","interventionNames":["Drug: Furosemide"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Furosemide","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects 18 years of age or older\n* Subjects with intrauterine pregnancy at or beyond 20 weeks of gestation\n* Subjects with a diagnosis of hypertensive disorder in pregnancy\n* Subjects with persistent (on repeat BP check 15 min apart) severe range blood pressure recordings (systolic BP greater than or equal to 160 or diastolic greater than or equal to BP 110) with wide pulse pressure (\\>60 mmHg)\n* Subject able to provide informed consent\n\nExclusion Criteria:\n\n* Subjects less than 18 years of age\n* Subjects with intrauterine pregnancy less than 20 weeks of gestation\n* Subjects with known fetal anomaly\n* Subjects with hypokalemia (K \\<3.0 milliequivalent per liter) on admission\n* Subjects with anuria (\\<50 milliliters urine in 24 hours) or renal failure\n* Subjects previously taking diuretics or potassium supplements for any reason\n* Subjects with a known allergy/adverse reaction to furosemide\n* Subjects who are unable to understand and/or sign the informed consent\n* Subjects who are in active labor defined as 6 centimeters of cervical dilation or more\n* Subjects who have an epidural (neuraxial anesthesia) in place","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Systolic Blood Pressure During Hour After Study Drug","description":"Mean systolic blood pressure during hour after study drug administration.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"147","spread":"14.8"},{"groupId":"OG001","value":"152","spread":"13.8"}]}]}]},{"type":"SECONDARY","title":"Mean Diastolic Blood Pressure During Hour After Study Drug","description":"Mean diastolic blood pressure during the 1-hour period after drug administration.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":"10.8"},{"groupId":"OG001","value":"87","spread":"9.3"}]}]}]},{"type":"SECONDARY","title":"Change From Qualifying Systolic Blood Pressure","description":"Change from qualifying systolic blood pressure (qualifying SBP-mean SBP during hour after intervention) where qualifying systolic blood pressure refers to a severe range SBP (\\>=160 millimeters of mercury (mmHg)) for at least 15 minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26","spread":"13.9"},{"groupId":"OG001","value":"-24","spread":"15.5"}]}]}]},{"type":"SECONDARY","title":"Change From Qualifying Diastolic Blood Pressure","description":"Change from qualifying diastolic blood pressure (qualifying DBP-mean DBP during hour after intervention) where qualifying diastolic blood pressure refers to a severe range DBP (\\>=110 millimeters of mercury (mmHg)) for at least 15 minutes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12","spread":"7.6"},{"groupId":"OG001","value":"-11","spread":"8.9"}]}]}]},{"type":"SECONDARY","title":"Pulse Pressure at 2 Hours After Study Drug.","description":"Pulse pressure at 2 hours after study drug.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":"12.5"},{"groupId":"OG001","value":"67","spread":"15.1"}]}]}]},{"type":"SECONDARY","title":"Systolic Blood Pressure at 2 Hours After Study Drug","description":"Systolic blood pressure at 2 hours after study drug","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"139","spread":"18.5"},{"groupId":"OG001","value":"154","spread":"18.4"}]}]}]},{"type":"SECONDARY","title":"Diastolic Blood Pressure at 2 Hours After Study Drug","description":"Diastolic blood pressure at 2 hours after study drug","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":"12.5"},{"groupId":"OG001","value":"87","spread":"10.5"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Gestational Age at Delivery","description":"Gestational age in weeks and days at the time of birth","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34.1","spread":"2.9"},{"groupId":"OG001","value":"34","spread":"3.1"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Time From Admission to Delivery","description":"Time in days and hours from admission to birth","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":null},{"groupId":"OG001","value":"3.7","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Time From Treatment to Delivery","description":"Time in days and hours from treatment to birth","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":null},{"groupId":"OG001","value":"1.8","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Induction of Labor","description":"Number of women who required induction of labor","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mode of Delivery","description":"Type of delivery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"8","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"22","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Eclampsia","description":"Number of women who developed seizure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Low Apgar Scores of Neonate (Apgar Score <7 at 5 Min)","description":"Neonatal clinical assessment (Apgar is not an abbreviated term). Minimum value 0; maximum value 9; Tool is used for assessment and not an accurate prognostic tool to predict outcomes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Newborns Admitted to Intensive Care Nursery","description":"Neonatal Intensive Care Unit admission","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Time to Achieve First Non-severe BP (m)","description":"Time to achieve first non-severe BP (m)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null},{"groupId":"OG001","value":"46","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Participants Who Required Additional Antihypertensive Agents in an Hour After Allocation","description":"Were any additional antihypertensive agents in hour after allocation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Latency Until Next First-line Antepartum Antihypertensive Agents","description":"time until next first-line antepartum antihypertensive agent given","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.8","spread":null},{"groupId":"OG001","value":"3.2","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Discharged Without Delivery","description":"proportion of participants who were discharged prior to delivery of the baby","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Length of Stay","description":"length of stay","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":null},{"groupId":"OG001","value":"7.3","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Birthweight","description":"weight of baby at birth","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1921","spread":"534.7"},{"groupId":"OG001","value":"2070","spread":"796.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":[]}}}